pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). And in 2023, these investments will hopefully pay off. Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”.

Marketing 90

Marketing Sales Medical Patients 90

European Pharmaceutical Review

OCTOBER 23, 2023

An intravesical drug delivery system designed to provide sustained local release of gemcitabine into the bladder, has enabled 77 percent of bladder cancer patients (23 out of 30) to achieve a complete response (CR) in the Cohort 2 of the Phase IIb SunRISe-1 study. Sanofi-Janssen collaboration to advance novel E.

Pharmaceutical 89

Pharmaceutical Safety Patients Leads 89

Pharmaceutical Technology

MAY 30, 2023

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. These drugs are set to make a combined $4.34bn in sales in 2028. Similarly, Almirall S.A.,

Sales 105

Sales Marketing Prescription Pharma 105

PM360

APRIL 18, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions.

Electronics 97

Electronics Healthcare Healthcare Healthcare Provider 97

Healthcare Success

DECEMBER 6, 2022

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. Patients Consumers are researching online, and their searches are becoming more sophisticated. Consumer-First Content is Essential.

Healthcare 112

Healthcare Healthcare Marketing Competition 112

PM360

OCTOBER 3, 2023

Director US Marketing and Patient Engagement, argenx US, Inc. Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc. PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Cardiology: Bradley A.

Education 122

Education Marketing Media Management 122

PM360

JULY 13, 2023

PM360 asked experts in helping patients stay on their prescribed therapies about where the industry could make the biggest improvements and how to better detect potential barriers. How can the industry better monitor and detect potential barriers to adherence for individual patients? How can they improve?

Medical 98

Medical Patients Education Transportation 98

PM360

JULY 13, 2023

“People adhere to medicines at a scale that should bewilder everyone in healthcare,” exclaims Grace Lomax, Clinical Director of Patient Connect , part of Clarivate. Little wonder 70% of patients with hypertension remain hypertensive and therefore at risk of myocardial infarctions (MIs) and cerebrovascular accidents.

Patients 98

Patients Education Medical Side effects 98

PM360

APRIL 18, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its ISPOR Real-World Evidence Summit 2023 scheduled for May 7 in Boston, MA, USA. The Summit is collocated with and being held immediately prior to the Society’s annual international conference, ISPOR 2023.

Food and Drug Administration 96

Food and Drug Administration Healthcare Healthcare Food 96

PM360

MARCH 22, 2024

Exploring the role of patient advocacy groups and clinical trials while discussing the challenges faced, and how artificial intelligence and modern methods revolutionize the landscape. As a result, newly diagnosed families frequently rely on patient advocacy groups (PAGs) for up-to-date information.

Patients 52

Patients Recruitment Ethics Government 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 88

Medicine Healthcare Healthcare Pharma 88

LEVO Health

JANUARY 31, 2023

Therefore, it is essential to become familiar with the role SEO strategy plays in healthcare marketing and healthcare SEO best practices that should be employed in 2023 to create a successful digital marketing plan. In turn, this may lead to more patients visiting your website and ultimately booking appointments at your practice.

Healthcare 96

Healthcare Healthcare Marketing Engineering 96

European Pharmaceutical Review

NOVEMBER 9, 2023

MANUFACTURING Continuous direct compression: opening up faster access to oral dose medication Deborah McElhone, CPI’s Medicines Manufacturing Innovation Centre IN-DEPTH FOCUS: QA/QC MICROBIOLOGY Bioburden and sterility testing: how to conserve gene therapy product Kathy Zagaroli, Senior Director of Quality Control at Kiniksa Pharmaceuticals Tom Bujold, (..)

Pharmaceutical 75

Pharmaceutical Manufacturing Medicine Management 75

pharmaphorum

DECEMBER 22, 2022

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. We can now measure patient activity, steps, and movement continuously and in real time, which serves as a new potential indicator of treatment effectiveness.

FDA 79

FDA Patients Electronics Medical 79

Pharmaceutical Technology

JUNE 8, 2023

The use of 4D Molecular Therapeutics’ (4DMT) aerosolised gene therapy 4D-710 has improved the quality-of-life and spirometry-measured outcomes in three cystic fibrosis patients , based on early results from a Phase I/II study presented at this year’s annual meeting of the European Cystic Fibrosis Society (ECFS).

Patients 98

Patients Food and Drug Administration Food Safety 98

LEVO Health

DECEMBER 20, 2022

As 2023 approaches, there are several strategies you can adopt to improve your healthcare marketing efforts and grow your practice. Adopting the following six marketing strategies may help you stay competitive, bring in new patients, and grow your practice substantially. 6 Medical Marketing Strategies to Adopt in 2023.

Healthcare 98

Healthcare Healthcare Marketing Media 98

Pharma Marketing Network

SEPTEMBER 6, 2023

Consequently, campaigns are bombarding HCPs with content, inflicting meaningless touchpoints and falling short of their needs to help patients. The post Pharma Customer Engagement USA 2023 appeared first on Pharma Marketing Network. It’s time to surpass HCP expectations. Goodbye valueless interactions, hello HCP trust. Register now!

Pharma 40

Pharma Networking Marketing Leads 40

PM360

DECEMBER 14, 2023

A New Online Destination for HCPs HealthCentral Corporation , operator of leading digital platforms that serve patients living with chronic illness, their care partners, and health professionals, has announced the newest addition to its suite of HCP support sites: MedCentral.

Physicians 52

Physicians Pharma Medical Patients 52

PM360

DECEMBER 14, 2023

A standard dose of the medicine causes acute kidney damage in 20% of patients and 50% of those who receive higher dosages used to treat life-threatening infections on a broad spectrum. for adult patients with progressing desmoid tumors who require systemic treatment. The tablets are created by SpringWorks Therapeutics Inc.

Healthcare 52

Healthcare Healthcare FDA Education 52

Star OUTiCO

NOVEMBER 30, 2022

Reassess ahead of 2023. Q4 is all about company budgets so employers will be looking to get new starters over the line before 2023, which means competing with others and streamlining processes to make sure they secure the talent they’re after. Top 5 most in-demand soft skills for 2022. How to customise your LinkedIn profile url.

Recruitment 98

Recruitment Pharma Leads Competition 98

European Pharmaceutical Review

JANUARY 30, 2023

In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs. Ultimately, this can lead to a progressive decrease in mobility and other severe impairments.

Side effects 68

Side effects Medicine Marketing Patients 68

pharmaphorum

NOVEMBER 17, 2022

Astellas Pharma’s zolbetuximab – currently leading an expanding pack of drugs targeting claudin 18.2 – has shown efficacy in the first of a pair of phase 3 trials of gastric or gastroesophageal junction (GEJ) adenocarcinoma. biomarker in more than 75% of their cells, the threshold for being deemed claudin 18.2

Leads 52

Leads Patients Manufacturing FDA 52

European Pharmaceutical Review

MARCH 2, 2023

This article explores some of the most notable developments of 2022, and areas that are likely to be a growing focus for data-driven transformation in 2023. EU Clinical Trial Information System From February 2023 all new clinical trials applications must be submitted via the new portal.

Food and Drug Administration 78

Food and Drug Administration Government Management Medicine 78

Pharmaceutical Technology

APRIL 28, 2023

Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. In 2022, US sales of Ozempic contributed to 65% of global sales; this is expected to continue, with the US market forecast to continue capturing the majority of sales, generating $71bn between 2023–2029.

Sales 52

Sales Marketing Medical Patients 52

European Pharmaceutical Review

MAY 2, 2023

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. 1,2 In the EU, an estimated 2.7

Patients 94

Patients Medicine Marketing Medical 94

pharmaphorum

DECEMBER 16, 2022

17 th March 2023 | JW Marriott Grosvenor House. The PM Society is delighted to announce a brand new, free of charge, category in the PM Society Awards 2023. The PM Society is a not-for-profit organisation that believes excellent healthcare communications leads to better outcomes for patients. PM Society Awards.

Networking 52

Networking Healthcare Healthcare Pharma 52

Pharmaceutical Technology

APRIL 12, 2023

Pharming Group has conducted the first commercial shipments of oral selective PI3Kδ inhibitor Joenja (leniolisib) to patients diagnosed with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in the US. In March 2023, Joenja secured approval from the US Food and Drug Administration (FDA) to treat the targeted patients.

Food and Drug Administration 59

Food and Drug Administration Patients FDA Food 59

Pharmacy Times

JUNE 13, 2023

More than ever, patients are turning to OTC products to treat conditions like allergies, arthritis, coughs, colds, migraines, and gastrointestinal issues.

Leads 26

Leads Patients 26

European Pharmaceutical Review

JANUARY 18, 2024

An attractive destination for ATMP clinical trials Based on the Cell and Gene Therapy Catapult (CGT Catapult)’s recently published UK 2023 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database , the UK is an attractive location for ATMP clinical trials. There were 175 ongoing trials in 2023, compared to 178 in 2022.

Distribution 91

Distribution Manufacturing Medicine Government 91

European Pharmaceutical Review

JUNE 5, 2023

Ninety-four percent of advanced stage (3 or 4) classic Hodgkin lymphoma patients treated with nivolumab, a PD-1 checkpoint inhibitor plus AVD chemotherapy (N-AVD) had one-year progression-free survival (PFS), according to Phase III trial results. Then 487 were part of the BV-AVD group.

Patients 75

Patients Side effects Healthcare Healthcare 75

pharmaphorum

JULY 20, 2022

” “This is an efficient, repeatable approach for more than a thousand known genetic diseases in which a patient is under-expressing a key protein,” said Mandel-Brehm. CAMP4’s drug aims to upregulate the function of SCN1A in the hope of eliminating seizures, and is due to start human trials in mid-2023.

Leads 52

Leads Medicine Patients Management 52

PM360

APRIL 7, 2023

Patient Pages: How Healthcare Costs Affect Insured Patients Today A new study shows an insured American with an employer-sponsored health insurance plan can expect to spend more than $320,000 (including insurance premiums and out-of-pocket costs) during his/her adult lifetime.

Healthcare 52

Healthcare Healthcare Insurance Physicians 52

PM360

OCTOBER 5, 2023

In total, PM360 , a leading life sciences marketing industry trade publication, recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives. Cardiology: Bradley A.

Education 52

Education Marketing Media Biopharma 52

PM360

DECEMBER 14, 2022

If you are curious as to what will be the biggest trends and changes in 2023, we asked 10 industry experts to peer into their crystal ball and let us know what to expect. That’s because PM360 is here to help you in all facets of your career, and we will continue to do so throughout 2023 to ensure you have a great year.

Marketing 52

Marketing Leads Patients 52

PM360

JANUARY 19, 2023

In the life sciences that can mean imagining better treatments, devices, and diagnostics to help improve patient outcomes and quality of life. Or imagining better ways to reach and engage with providers, patients, and payers to ensure everyone who needs these treatments is aware of them and has access to them.

Marketing 52

Marketing Healthcare Healthcare Pharmaceutical 52

MedTechVets

OCTOBER 23, 2023

October 23rd, 2023– On October 10th, MedTechVets hosted a Breakfast Networking Panel titled, “Veteran Impact on MedTech” at The MedTech Conference in Anaheim, California. The post MedTechVets Breakfast Panel Recap, 2023 MedTech Conference appeared first on MedTechVets. And hearts of service.

Networking 59

Networking Training Medical Patients 59

PM360

APRIL 7, 2023

Reduced patient out-of-pocket (OOP) costs in Part D have the potential to reduce beneficiary reliance on foundation support, with commensurate reductions in manufacturer donations required. The business-to-business market leaders must find new and creative ways to help patients receive their treatments.

Manufacturing 97

Manufacturing Insurance Government Marketing 97